SLF
VRTX icon

Sun Life Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Sun Life Financial’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-156
Closed -$34K – 470
2021
Q1 		$34K Buy
156
+2
+1% +$439 ﹤0.01% 207
2020
Q4 		$36K Sell
154
-3
-2% -$688 ﹤0.01% 197
2020
Q3 		$43K Buy
157
+3
+2% +$828 0.01% 170
2020
Q2 		$45K Sell
154
-1
-0.6% -$271 0.01% 153
2020
Q1 		$37K Buy
155
+5
+3% +$1.15K 0.01% 147
2019
Q4 		$33K Sell
150
-60
-29% -$12.1K 0.01% 171
2019
Q3 		$36K Buy
210
+3
+1% +$531 0.01% 330
2019
Q2 		$38K Sell
207
-227
-52% -$39.7K 0.01% 319
2019
Q1 		$80K Sell
434
-272
-39% -$50.2K 0.02% 297
2018
Q4 		$117K Buy
706
+9
+1% +$1.56K 0.02% 272
2018
Q3 		$134K Buy
697
+5
+0.7% +$890 0.02% 293
2018
Q2 		$118K Buy
692
+503
+266% +$78K 0.02% 300
2018
Q1 		$1.16K Sell
189
-366
-66% -$59.8K 0.01% 306
2017
Q4 		$83K Sell
555
-1,296
-70% -$192K 0.01% 208
2017
Q3 		$281K Buy
1,851
+53
+3% +$7.98K 0.03% 187
2017
Q2 		$232K Buy
1,798
+1,786
+14,883% +$215K 0.02% 208
2017
Q1 		$110 Buy
+12
New +$1.06K ﹤0.01% 379

Other funds holding VRTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Sun Life Financial's VRTX Position: Q2 2021 in Review

Sun Life Financial sold out of Vertex Pharmaceuticals (VRTX) in Q2 2021, closing a stake of 156 shares — an estimated $34K sold.

Sun Life Financial first reported a position in VRTX in Q1 2017 and held it in 17 quarters. The position peaked at $281K in Q3 2017. 978 funds tracked by Wall St. Rank hold VRTX as of Q2 2021.

  • Sun Life Financial reported no remaining Vertex Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Sun Life Financial sold 156 Vertex Pharmaceuticals shares in Q2 2021, an estimated $34K.
  • Sun Life Financial first reported a position in Vertex Pharmaceuticals in Q1 2017 and held it in 17 quarters.
  • Sun Life Financial's Vertex Pharmaceuticals position peaked at $281K in Q3 2017.
  • 978 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2021.

Based on Sun Life Financial's 13F filing for Q2 2021, filed 10 Aug 2021.